RAS has a high mutation rate in melanoma, and studies have found that the inactivation of RAS can lead to rapid death of tumor cells and tumor degeneration, [23] and targeted inhibition of NRAS is also an effective treatment method. This evidence concerns the gene NRAS and melanoma.